ARWR vs ECL · rev $829.4M vs P/E 35, rev $4.01B
Arrowhead Pharmaceuticals Inc (ARWR) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
ARWR currently screens at market cap $10.59B. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the ARWR and ECL stock pages for the full models.
Not investment advice.